{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T17:42:21Z","timestamp":1744566141524,"version":"3.40.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.thromres.2012.08.302","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T06:01:16Z","timestamp":1346306476000},"page":"e216-e221","source":"Crossref","is-referenced-by-count":13,"title":["Fibrin clot properties in women heterozygous for factor V Leiden mutation: Effects of oral contraceptives"],"prefix":"10.1016","volume":"130","author":[{"given":"Marzena","family":"Krzek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariola","family":"Ciesla-Dul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Zabczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2012.08.302_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"16","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.08.302_bb0010","doi-asserted-by":"crossref","first-page":"0751","DOI":"10.1371\/journal.pmed.0050097","article-title":"Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis","volume":"5","author":"Meltzer","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.thromres.2012.08.302_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1160\/TH11-03-0184","article-title":"Venous thromboembolism in Asia \u2013an unrecognised and under-treated problem?","volume":"106","author":"Anqchisuksiri","year":"2011","journal-title":"Thromb Hemost"},{"key":"10.1016\/j.thromres.2012.08.302_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH07-02-0150","article-title":"Coagulation factor V and thrombophilia: Background and mechanisms","volume":"98","author":"Segers","year":"2007","journal-title":"Thromb Hemost"},{"issue":"SV","key":"10.1016\/j.thromres.2012.08.302_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1378\/chest.124.3_suppl.33S","article-title":"Thrombin and fibrinolysis","volume":"124","author":"Nesheim","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2012.08.302_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.thromres.2012.08.302_bb0035","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/TH07-04-0302","article-title":"Coagulation at the site of microvascular injury in healthy and coumadin-treated subjects heterogenous for factor V Leiden mutation","volume":"98","author":"Undas","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.08.302_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.thromres.2011.06.030","article-title":"Thrombomodulin-dependent effect of factor V Leiden mutation on factor XIII activation","volume":"129","author":"Koncz","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.08.302_bb0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0950-3552(97)80027-2","article-title":"Haemostatic changes and the oral contraceptive pill","volume":"11","author":"Norris","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.thromres.2012.08.302_bb0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.contraception.2008.06.008","article-title":"The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives","volume":"78","author":"Gartner","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2012.08.302_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00001721-200207000-00001","article-title":"Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation","volume":"13","author":"Kemmeren","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2012.08.302_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9378(99)70699-X","article-title":"Effects of oral contraceptives on hemostasis and thrombosis","volume":"180","author":"Rosing","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.thromres.2012.08.302_bb0065","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.08.302_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/STROKEAHA.108.532812","article-title":"Altered fibrin clot structure\/function as a novel risk factor for cryptogenic ischemic stroke","volume":"40","author":"Undas","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2012.08.302_bb0075","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: A role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.08.302_bb0080","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.08.302_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.08.302_bb0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3324\/haematol.2010.023432","article-title":"Deep venous thrombosis or pulmonary embolism and factor V Leiden: Enigma or paradox","volume":"95","author":"Corral","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2012.08.302_bb0095","doi-asserted-by":"crossref","first-page":"22949","DOI":"10.1074\/jbc.271.38.22949","article-title":"An antifibrinolytic mechanism describing the prothrombotic effect associated with Factor V Leiden","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.08.302_bb0100","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/01.CIR.0000148781.87906.C0","article-title":"Factor V Leiden inhibits fibrinolysis in vivo","volume":"110","author":"Parker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2012.08.302_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0037-1613959","article-title":"Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis. A randomized cross-over study of two low-dose oral contraceptives","volume":"84","author":"Meijers","year":"2000","journal-title":"Thromb Hemost"},{"key":"10.1016\/j.thromres.2012.08.302_bb0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2007.05.028","article-title":"Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress","volume":"196","author":"Undas","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2012.08.302_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2012.08.302_bb0120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MBC.0b013e328338db3f","article-title":"Shorter preoperative fibrin clot lysis time predisposes to higher chest tube drainage in patients undergoing elective coronary artery bypass grafting surgery","volume":"21","author":"Undas","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2012.08.302_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.20452\/pamw.1083","article-title":"Acquired dysfibrinogemia in atherosclerotic vascular disease","volume":"121","author":"Undas","year":"2011","journal-title":"Pol Arch Med Wew"},{"key":"10.1016\/j.thromres.2012.08.302_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0268-9499(97)80101-4","article-title":"Effects of third generation oral contraceptives containing newly developed progestagens on fibrinolytic parameters","volume":"11","author":"Quehenberger","year":"1997","journal-title":"Fibrinolysis Proteol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812006780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812006780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:11:21Z","timestamp":1744035081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812006780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0049384812006780"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.08.302","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}